Literature DB >> 15386442

Oxidative stress and serum paraoxonase activity in experimental hypothyroidism: effect of vitamin E supplementation.

Emre Sarandöl1, Sibel Taş, Melahat Dirican, Zehra Serdar.   

Abstract

Thyroid hormones are associated with the oxidative and antioxidative status of the organism. Since data on the oxidative status of hypothyroidism are limited and controversial, we investigated the oxidant and antioxidant status and serum paraoxonase/arylesterase activities in propylthiouracil-induced hypothyroidism and examined the effect of vitamin E supplementation on this experimental model. Forty male Sprague Dawley rats were randomly divided into four groups (group 1, control; group 2, control + vitamin E; group 3, propylthiouracil; group 4, propylthiouracil + vitamin E). Plasma, red blood cell, liver, heart and skeletal muscle malondialdehyde levels were increased in the propylthiouracil-treated group compared with the control rats and were decreased in propylthiouracil + vitamin E group compared with the propylthiouracil-treated group. Vitamin E supplementation also significantly increased liver and kidney reduced glutathione levels in propylthiouracil treated animals. Serum paraoxonase and arylesterase activities were decreased in propylthiouracil treated group and vitamin E supplementation caused significant increase in serum paraoxonase activity compared with the propylthiouracil-treated rats. These findings suggest that hypothyroidism is accompanied with increased oxidative stress and vitamin E supplementation exerts beneficial effects on this situation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15386442     DOI: 10.1002/cbf.1119

Source DB:  PubMed          Journal:  Cell Biochem Funct        ISSN: 0263-6484            Impact factor:   3.685


  22 in total

Review 1.  Pharmacological and dietary modulators of paraoxonase 1 (PON1) activity and expression: the hunt goes on.

Authors:  Lucio G Costa; Gennaro Giordano; Clement E Furlong
Journal:  Biochem Pharmacol       Date:  2010-11-18       Impact factor: 5.858

2.  T-wave inversions on ECG as primary manifestation of Hashimoto's disease.

Authors:  Katherine A Araque; Michael J Smith; Brooks M Walsh
Journal:  BMJ Case Rep       Date:  2016-04-07

3.  Curcumin and vitamin E modulate hepatic antioxidant gene expression in PTU-induced hypothyroid rats.

Authors:  U Subudhi; G B N Chainy
Journal:  Mol Biol Rep       Date:  2012-06-24       Impact factor: 2.316

4.  Role of levothyroxine and vitamin E supplementation in the treatment of oxidative stress-induced injury and apoptosis of myocardial cells in hypothyroid rats.

Authors:  J Ye; X Zhong; Y Du; C Cai; T Pan
Journal:  J Endocrinol Invest       Date:  2017-02-17       Impact factor: 4.256

5.  Hypothyroid heart: myxoedema as a cause of reversible dilated cardiomyopathy.

Authors:  Nidhi Madan; Nidhish Tiwari; Morris Stampfer; Ulrich Schubart
Journal:  BMJ Case Rep       Date:  2015-10-14

Review 6.  The human paraoxonase gene cluster as a target in the treatment of atherosclerosis.

Authors:  Zhi-Gang She; Hou-Zao Chen; Yunfei Yan; Hongliang Li; De-Pei Liu
Journal:  Antioxid Redox Signal       Date:  2011-10-18       Impact factor: 8.401

7.  Proanthocyanidin as a cytogenetic protective agent against adverse effects of plant growth regulators supplementation in rats.

Authors:  Hanaa A Hassan; Wafaa M El-Kholy; Samar E Nour
Journal:  Cytotechnology       Date:  2013-07-31       Impact factor: 2.058

Review 8.  Vitamin E management of oxidative damage-linked dysfunctions of hyperthyroid tissues.

Authors:  Paola Venditti; Lisa Di Stefano; Sergio Di Meo
Journal:  Cell Mol Life Sci       Date:  2012-12-20       Impact factor: 9.261

9.  Taurine ameliorated thyroid function in rats co-administered with chlorpyrifos and lead.

Authors:  Motunrayo Ganiyat Akande; Muftau Shittu; Chidiebere Uchendu; Lukuman Surakat Yaqub
Journal:  Vet Res Commun       Date:  2016-08-25       Impact factor: 2.459

10.  Serum ischemic modified albumin levels might not be a marker of oxidative stress in patients with hypothyroidism.

Authors:  Kerem Ersoy; İnan Anaforoğlu; Ekrem Algün
Journal:  Endocrine       Date:  2012-09-23       Impact factor: 3.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.